31 July, 2014 10:53 IST
News
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS (19-NOV-12)
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*


Live News
Sensex edges higher; metal up, IT down - 31-Jul-2014 10:41
Call rate rises 22 bps to 8.11% - 31-Jul-2014 10:30
Dollar-rupee futures gain 12 paise at 60.52 - 31-Jul-2014 10:16
Rupee declines 16 paise against dollar to 60.22 - 31-Jul-2014 10:11
HCL Technologies slips post Q4 earnings - 31-Jul-2014 10:01
HCL Tech Q4 profit surges 53.7%; up 13% sequentially - 31-Jul-2014 09:47
Sensex flat in early trade; Sesa Sterlite up, TCS down - 31-Jul-2014 09:30
Markets likely to open on flat note: ICICIdirect - 31-Jul-2014 09:10
Market likely to trade in range between 7,820-7,830 in upper side: Indira Sec - 31-Jul-2014 09:07
Trend deciding level for day is 26,017/7,766: Angel Broking - 31-Jul-2014 09:04
Indian ADRs higher; Dr Reddy, ICICI Bank lead - 31-Jul-2014 08:59
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   tmhd68 into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer